Lead drug for treating ALS
搜索文档
Here’s Greenlight Capital’s Update on Coya Therapeutics (COYA)
Yahoo Finance· 2025-10-28 19:41
Greenlight Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Greenlight Capital funds returned -3.6% in the quarter, net of fees and expenses, compared to 8.1% for the S&P 500 index. The fund returned 0.4% in YTD compared to 14.8% for the index. For more information on the fund’s top picks in 2025, please check its top five holdings. In its third-quarter 2025 investor letter, Greenlight Capital highlighted stocks suc ...